Welcome to LookChem.com Sign In|Join Free

CAS

  • or

267413-29-6

Post Buying Request

267413-29-6 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

267413-29-6 Usage

Structure

A derivative of indazole, containing a bicyclic structure with a benzene ring fused to a pyrazole ring.

Usage

Synthesis of pharmaceuticals, agrochemicals, and other organic compounds.

Physical appearance

White to off-white solid.

Molecular weight

161.17 g/mol.

Potential applications

Development of new drugs and biological research.

Unique properties

Chemical and biological properties that contribute to its potential use in various applications.

Check Digit Verification of cas no

The CAS Registry Mumber 267413-29-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,6,7,4,1 and 3 respectively; the second part has 2 digits, 2 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 267413-29:
(8*2)+(7*6)+(6*7)+(5*4)+(4*1)+(3*3)+(2*2)+(1*9)=146
146 % 10 = 6
So 267413-29-6 is a valid CAS Registry Number.

267413-29-6SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name 1-methylindazole-6-carbonitrile

1.2 Other means of identification

Product number -
Other names 1-Methyl-1H-indazole-6-carbonitrile

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:267413-29-6 SDS

267413-29-6Relevant articles and documents

FACTOR XIIA INHIBITORS

-

Paragraph 00270-00272, (2019/10/19)

This invention relates to compoundsof formula (I)and methods of treatment using the compounds. The invention also relates to processes and methods for producing the compounds of the invention. The compounds of the invention are modulators of Factor XII (e.g. Factor XIIa). In particular, the compounds are inhibitors of Factor XIIa and may be useful as anticoagulants.

Palladium-catalyzed direct C7-arylation of substituted indazoles

Naas, Mohammed,El Kazzouli, Sa?d,Essassi, El Mokhtar,Bousmina, Mosto,Guillaumet, Gérald

, p. 7286 - 7293 (2014/09/16)

A novel direct C7-arylation of indazoles with iodoaryls is described using Pd(OAc)2 as catalyst, 1,10-phenanthroline as ligand, and K 2CO3 as base in refluxing DMA. Direct C7-arylation of 3-substituted 1H-indazole containing an EWG on the arene ring gave the expected products in good isolated yields. In addition, a one-pot Suzuki-Miyaura/ arylation procedure leading to C3,C7-diarylated indazoles has been developed.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 267413-29-6